期刊文献+

糖尿病肾病患者尿液中生物学标记物的表达及其与急性肾损伤发生的相关性 被引量:1

下载PDF
导出
摘要 目的:观察糖尿病肾病患者尿液中生物学标记物的表达,分析其与糖尿病肾病患者发生急性肾损伤的关系。方法:选择2020年5月—2022年5月医院收治的90例糖尿病肾病患者作为研究对象,其中Ⅰ期30例,Ⅱ期29例,Ⅲ期31例。采集所有患者尿液标本并用ELISA法检测患者体内中性粒细胞明胶酶相关的脂质运载蛋白(NGAL)、肾损伤分子1(KIM-1)、尿白细胞介素18(IL-18)水平,比较尿液中生物学标记物表达在Ⅰ~Ⅲ期糖尿病肾病患者中的变化。根据是否并发急性肾损伤将患者分为发生组和未发生组,比较两组患者NGAL、KIM-1、尿IL-18水平,分析上述指标与急性肾损伤发生的相关性。结果:Ⅰ期患者NGAL、KIM-1水平均低于Ⅱ期以及Ⅲ期,且Ⅱ期低于Ⅲ期,差异有统计学意义(P<0.05)。未发生组患者尿液中NGAL、KIM-1及IL-18水平均低于发生组,差异有统计学意义(P<0.05);点二列相关性分析可得,尿液中NGAL、KIM-1、IL-18与糖尿病肾病患者合并急性肾损伤均呈正相关性(P<0.05)。结论:尿液中NGAL、KIM-1水平与糖尿病肾病患者的病情相关。尿液中NGAL、KIM-1、IL-18水平越高,糖尿病肾病患者发生急性肾损伤的危险性越高。
作者 郭洋洋
出处 《医学理论与实践》 2023年第20期3537-3539,共3页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献8

二级参考文献77

  • 1Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a ma- jorculprit in kidney disease in diabetes. Diabetes,2008,57 (6) : 1446 - 1454.
  • 2Boussageon R, Bejan - Angoulvant T, Saadatian - Elahi M, et al. Effect of intensive glucose lowering treatment on all - cause mor- tality, cardiovascular death, and microvaseular events in type 2 diabetes:meta - analysis of randomized controlled trials. BMJ, 2011,343 : d4169.
  • 3Krolewski AS, Niewezas MA, Skupien J, et al. Early progressive renal decline precedes the onset of microalbuminuria and it s pro- gression to maeroalbuminuria. Diabetes Care, 2014,37 ( 1 ) : 226 - 234.
  • 4Wang G, Lai FM, Lai KB, et al. Messenger RNA expression podo- cyte - associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clin Pract, 2007,106 ( 4 ) : c169 - c179.
  • 5Hara M, Yamagata K,Tomino Y, et al. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes:estab- lishment of a highly sensitive ELISA to detect urinary podocalyx- in. Diabetologia,2012,55 ( 1 l ) :2913 - 2919.
  • 6Nielsen JS, McNagny KM. The role of podocalyxin in health and disease. J Am Soc Nephrol,2009,20 ( 11 ) :1669 - 1676.
  • 7Zheng M, Lv LL, Ni J, et al. Urinary Podocyte - Associated mR- NA profile in Various Stages of Diabetic Nephropathy. PLoS One, 2011,6(5) : e20431.
  • 8Moreseo RN, Sangoi MB, De Carvalho JA, et al. Diabetic ne- phropathy: traditional to proteomic markers. Clin Chim Acta, 2013,421 ( 1 ) : 17 - 30.
  • 9Tesch GH. Review:serum and urine biomarkers of kidney dis- ease : a pathophysiological perspective Nephrology ( Carlton), 2010,15(6) :609 -616.
  • 10Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications, 1998,12 ( 1 ) :43 - 60. .

共引文献57

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部